Skip to main content
ARTIVION, INC. logo

ARTIVION, INC. — Investor Relations & Filings

Ticker · AORT ISIN · US2289031005 LEI · 549300YTKV8DMSMG6K81 US Manufacturing
Open in API
Filings indexed 1,531 across all filing types
Latest filing 2023-05-04 Earnings Release
Country US United States of America
Listing US AORT

About ARTIVION, INC.

https://artivion.com/

Artivion, Inc. is a medical device company focused on developing, manufacturing, and distributing solutions for cardiac and vascular surgery. The company has an intentional focus on creating technologies to treat diseases of the aorta. In collaboration with surgeons, Artivion develops products designed to address complex surgical challenges. Its portfolio includes a range of aortic-centric technologies, such as heart valve solutions, implantable human tissues (allografts), surgical sealants, and various stent grafts for the aortic arch, thoracoabdominal, abdominal, and peripheral aorta. The company's purpose is to provide simple, elegant solutions that improve surgical outcomes for patients with aortic diseases.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2023, for Artivion, Inc. It announces the issuance of a press release reporting financial results for the first quarter ended March 31, 2023. The document states that the press release is attached as Exhibit 99.1 and is 'furnished' but not 'filed'. The content is primarily an announcement of financial results rather than the full financial report itself. The document length is 5238 characters, which is relatively short and consistent with an earnings release announcement rather than a full report. The key section is 'Item 2.02 Results of Operations and Financial Condition', which is typically used for earnings releases. Therefore, this document is best classified as an Earnings Release (ER).
2023-05-04 English
ANNUAL REPORT TO SECURITY HOLDERS
Annual Report
2023-04-05 English
ADDITIONAL DEFINITVE MATERIAL
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy statement related to the Annual Meeting of Stockholders scheduled for May 16, 2023. It includes proxy voting instructions, election of directors, approval of executive compensation, ratification of the independent auditor, and approval of additional funding for an equity incentive plan. The document is titled 'ADDITIONAL DEFINITIVE MATERIAL' and references the proxy materials and voting procedures. It does not contain financial statements or detailed financial analysis but is focused on soliciting shareholder votes on governance and compensation matters. This type of document corresponds to a Proxy Solicitation & Information Statement (PSI).
2023-04-03 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2023-04-03 English
FORM 4
Director's Dealing
2023-03-04 English
FORM 4
Director's Dealing
2023-03-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.